OOIR: Observatory of International Research

Papers

(The TQCC of Nature Reviews Urology is 5. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-06-01 to 2025-06-01.)

Article	Citations
CDH12-expressing cell population predicts patient response to therapy	145
Krause corpuscles act as genital vibration detectors	130
Exploratory results from the CheckMate 214 trial	121
Immune infiltration associated with outcomes	113
Semen quality recovery following COVID-19	112
Novel intravesical gemcitabine delivery system (TAR-200) for neoadjuvant treatment of MIBC: context is everything	85
Texture analysis for patient selection	78
Single-cell and spatial sequencing of kidney cancer	68
Human-relevant urothelial model provides insight into infection strategies and host response	67
Sexual recovery interventions following prostate cancer treatment	60
Time for women-centred gynaecology	55
RAL-P in infants: expert tips for success	52
Implementation of patient-reported outcome measures into health care for men with localized prostate cancer	52
High-dose chemotherapy for relapsed testicular germ cell tumours	52
Preclinical models of bladder cancer: BBN and beyond	52
PARP inhibitors plus enzalutamide to treat mCRPC	50
Urine microbiota differ in bladder cancer	50
Considering urology in a planetary context	47
Advancing the state of the art in congenital obstructive uropathy	47
The potential of CAR T cell therapy for prostate cancer	46
Host–biomaterial interactions in mesh complications after pelvic floor reconstructive surgery	45
Top, bottom or vers? Creating a more equitable health system for sexual and gender minority patients with prostate cancer	45
A clinical guide to rare male sexual disorders	45
HIV pre-exposure prophylaxis and sexually transmitted infections: intersection and opportunity	44
FOXA2–KIT-driven lineage plasticity in NEPC	42

Proteomic-based analysis of testicular interstitial fluid	42
Prevalence of gender dysphoria in Japan	41
A new text message-based platform for self-management of patients with IC/BPS	40
Microfluidic sperm selection	40
Evolution of the World Health Organization semen analysis manual: where are we?	39
Ibrexafungerp to treat acute vulvovaginal candidiasis	38
Madrid plays host to a celebration of urology	37
Galectins as potential therapeutic targets in STIs in the female genital tract	37
Metaverse in surgery — origins and future potential	36
Is SARS-CoV-2-induced testicular damage in hamsters relevant?	35
Reducing the stigma of academic mental health can save lives	34
Hallmark discoveries in the biology of non-Wilms tumour childhood kidney cancers	34
The evolving landscape of monogenic nephrolithiasis and therapeutic innovations	34
Overcoming antibiotic resistance in complicated UTI	33
What happens in Vegas … shapes the future of urology	33
A non-invasive assay for UTUC diagnosis	32
Prognostic and therapeutic potential of senescent stromal fibroblasts in prostate cancer	32
Mirabegron safe and effective for NDO	31
Resolving the puzzle of same-sex sexual interactions	31
Pembrolizumab + axitinib beyond first-line therapy for mRCC	31
Antibiotic therapy for treating overactive bladder is not supported by clinical evidence	30
Measuring and improving the cradle-to-grave environmental performance of urological procedures	30
Bioinformatics in urology — molecular characterization of pathophysiology and response to treatment	29
Incorporating palliative care principles to improve patient care and quality of life in urologic oncology	28
Vaccination to prevent untreatable gonorrhoea	27
Quest for a genetic biomarker for sickle cell disease priapism: rationale, progress and implications	27
COVID can’t kill CopMich collaboration	27
177Lu–PSMA-PET extends survival	27
The mechanism of action of neuromodulation in the treatment of overactive bladder	27
Personalized 3D models for prostate cancer surgery	26
Efficacy of the Revi system in treating urgency urinary incontinence	26
Pain management in percutaneous nephrolithotomy — an approach rooted in pathophysiology	25
PEACEing together prostate cancer therapy	25
Prostate cancer in transgender women — challenges in research and clinical care	24
Is it time to rethink the current patient-reported outcome measures?	24
Quality checkpoints in the MRI-directed prostate cancer diagnostic pathway	24
Author Correction: Can PROMs improve racial equity in outcomes after prostatectomy?	24
Effect of high glucose on E. coli	24
Robots learning to imitate surgeons — challenges and possibilities	24
Molecular events in neuroendocrine prostate cancer development	24
Sexual orientation, gender identity and COVID: a complicated picture	23
Secondary kidney stones — remove or leave?	22
A clinical overview of people living with HIV and genitourinary cancer care	22
Rucaparib improves PFS in patients with BRCA1/2-altered mCRPC	21
Women in urology: the past	21
AUA returns to its former glory in Chicago	21
Cribriform morphology affects mpMRI imaging	21
Successful mentorship for women in urology — a new era	21
The magic of MagSToNE	21
Videourodynamics — role, benefits and optimal practice	20

Centralization of care for rare genetic syndromes associated with cancer: improving outcomes and advancing research on VHL disease	20
Promising efficacy of UTI vaccines as an alternative to antibiotics	20
Microultrasonography-guided prostate cancer biopsy	20
A distinct TAM subset mediates immunotherapy resistance in prostate cancer	20
Racial disparities in prostate cancer in the UK and the USA: similarities, differences and steps forwards	19
Current and emerging strategies to curb antibiotic-resistant urinary tract infections	19
The placebo and nocebo effects in functional urology	19
Sexual health and treatment-related sexual dysfunction in sexual and gender minorities with prostate cancer	18
Going in circles: circMGA–HNRNPL feedback loop in bladder cancer	18
Androgen receptor pathway inhibitor combination in prostate cancer	18
Metabolic response to immunotherapy in prostate cancer	18
De-clear cell differentiated renal cell carcinoma — a new therapeutic target	17
Management and cost of stent encrustation in pregnancy	16
Detecting lymph node metastases for personalized radiotherapy in patients with prostate cancer	16
Using oncolytic viruses to ignite the tumour immune microenvironment in bladder cancer	15
The evolving treatment landscape of metastatic urothelial cancer	14
Overall survival with adjuvant pembrolizumab in renal cell carcinoma — the shock of the lightning	14
Turning up the heat: CTLA4 blockade in urothelial cancer	14
Immune-based therapies in penile cancer	14
Evolving language reflects evolving understanding: updated terms for anatomical description in i/VSC/DSD	13
Pride, not prejudice	12
The future of patient-derived xenografts in prostate cancer research	11
The prognostic role of stroma in UTUC	11
Recurrence mechanisms of non-muscle-invasive bladder cancer — a clinical perspective	11
We all get erections — de-gendering sexual arousal dysfunction in the ICD	10
Breaking the silence: normalizing receptive anal intercourse for patients, for people and for myself	10
Prostate cancer screening: a new way forward or another false start?	10
Uncovering a link between COVID-19 and renal cell carcinoma	10
Hypoxia-inducible factor 2 inhibitors show promise in advanced kidney cancer	10
The shifting treatment paradigm of metastatic renal cell carcinoma	10
The value of women urologists — individual and institutional imperatives to address salary equity	10
The unclear role of PET–CT in localized radiorecurrent prostate cancer	10
Hallmark discoveries in the biology of Wilms tumour	10
BAUSing back in Birmingham	9
Improved phenotypic classification of male infertility to promote discovery of genetic causes	9
Vitamins as regulators of calcium-containing kidney stones — new perspectives on the role of the gut microbiome	9
Mitomycin C plus cytosine arabinoside for NMIBC	9
Neoadjuvant lutetium PSMA, the TIME and immune response in high-risk localized prostate cancer	9
Tuft cells in prostate cancer	8
CMA mediates resistance to androgen inhibitors in prostate cancer	8
Men hold the balance of power	8
Power up to investigate PrEP	8
Understanding iGCA	8
Patient selection is key in IMbassador250	8
Effects of COVID-19 vaccine on semen parameters	8
Metabolism, mitochondria and metastasis in kidney cancer	7
Salvage therapy for prostate cancer after radical prostatectomy	7
Mechanisms of the intestinal and urinary microbiome in kidney stone disease	7
Mellow yellow: BilR reduces bilirubin to urobilinogen	7
Microbiota manipulation to prevent oxalate kidney stone formation	7
Spatiotemporal trends in human semen quality	7
ARNEO: neoadjuvant degarelix + apalutamide before surgery for high-risk prostate cancer	7
Diagnosis of ccRCC	7
Male infertility and somatic health — insights into lipid damage as a mechanistic link	7
Semen parameters across testicular cancer stages	7
Sperm activity affected by endometriosis	6
Genetic ancestry and racial differences in prostate tumours	6
Pronouns in English: a user’s guide	6
A prompt-based stewardship to reduce extended-spectrum antibiotic treatment in UTI	6
MRI diagnosis and radical prostatectomy outcomes	6
Practical considerations for prostate hypofractionation in the developing world	6
Mechanisms of the Supra-T paradox	6
The ins and outs of penile erection	6
Toilet-based continuous health monitoring using urine	5
Influence of substance use on male reproductive health and offspring outcomes	5
Genetic and biological drivers of prostate cancer disparities in Black men	5
Chlorination by-products in drinking water — association with bladder cancer risk	5
Pathophysiology and potential multimodal therapeutic strategies for IC/BPS	5
Probiotics to treat chronic bacterial prostatitis	5
Clinical trial design for non-muscle-invasive bladder cancer	5
Urology on a changing planet: links between climate change and urological disease	5
Prostate luminal progenitor cells: from mouse to human, from health to disease	5
Syphilis on the rise — a need for alternative therapies and vaccines	5
Testosterone replacement therapy and spermatogenesis in reproductive age men	5
A great gathering at the 4th Clinical and Scientific Advances in UTI conference	5
Artificial intelligence in the management of prostate cancer	5
Particulate matter leaves a bitter taste in testes	5
Advances in sliding clip renorrhaphy for partial nephrectomy	5
Stepping up to prevent bacterial vaginosis recurrence	5